272 related articles for article (PubMed ID: 37240346)
1. Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain.
Ciapała K; Rojewska E; Pawlik K; Ciechanowska A; Mika J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240346
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia.
Popiolek-Barczyk K; Makuch W; Rojewska E; Pilat D; Mika J
Pharmacol Rep; 2014 Oct; 66(5):845-51. PubMed ID: 25149989
[TBL] [Abstract][Full Text] [Related]
3. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.
Ciechanowska A; Rojewska E; Piotrowska A; Barut J; Pawlik K; Ciapała K; Kreiner G; Mika J
Front Immunol; 2022; 13():1058204. PubMed ID: 36618360
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
5. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
[TBL] [Abstract][Full Text] [Related]
6. Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model.
Rojewska E; Ciapała K; Mika J
Pharmacol Rep; 2019 Feb; 71(1):139-148. PubMed ID: 30550994
[TBL] [Abstract][Full Text] [Related]
7. PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy.
Rojewska E; Popiolek-Barczyk K; Kolosowska N; Piotrowska A; Zychowska M; Makuch W; Przewlocka B; Mika J
PLoS One; 2015; 10(10):e0138583. PubMed ID: 26426693
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
Front Immunol; 2021; 12():781310. PubMed ID: 34795678
[TBL] [Abstract][Full Text] [Related]
9. CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain.
Bogacka J; Ciapała K; Pawlik K; Kwiatkowski K; Dobrogowski J; Przeklasa-Muszynska A; Mika J
Front Immunol; 2020; 11():1241. PubMed ID: 32760393
[TBL] [Abstract][Full Text] [Related]
10. Effect of pharmacological modulation of the kynurenine pathway on pain-related behavior and opioid analgesia in a mouse model of neuropathic pain.
Ciapała K; Pawlik K; Ciechanowska A; Mika J; Rojewska E
Toxicol Appl Pharmacol; 2023 Feb; 461():116382. PubMed ID: 36681127
[TBL] [Abstract][Full Text] [Related]
11. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors.
Zhao X; Li XL; Liu X; Wang C; Zhou DS; Ma Q; Zhou WH; Hu ZY
Pharmacol Res; 2015 Dec; 102():286-97. PubMed ID: 26520392
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of combined morphine and MK-801 administration to the locus coeruleus of a rat neuropathic pain model.
Llorca-Torralba M; Mico JA; Berrocoso E
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):257-266. PubMed ID: 29524514
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 Activation Attenuates Chronic Constriction Injury-Induced Neuropathic Pain via Induction of PGC-1
Sun J; Li JY; Zhang LQ; Li DY; Wu JY; Gao SJ; Liu DQ; Zhou YQ; Mei W
Oxid Med Cell Longev; 2021; 2021():9577874. PubMed ID: 34721761
[TBL] [Abstract][Full Text] [Related]
15. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
Bogacka J; Popiolek-Barczyk K; Pawlik K; Ciechanowska A; Makuch W; Rojewska E; Dobrogowski J; Przeklasa-Muszynska A; Mika J
Eur J Pharmacol; 2020 Aug; 880():173166. PubMed ID: 32407723
[TBL] [Abstract][Full Text] [Related]
16. The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
Pawlik K; Piotrowska A; Kwiatkowski K; Ciapała K; Popiolek-Barczyk K; Makuch W; Mika J
Immunology; 2020 Apr; 159(4):413-428. PubMed ID: 31919846
[TBL] [Abstract][Full Text] [Related]
17. Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics.
Ciapała K; Mika J
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004489
[TBL] [Abstract][Full Text] [Related]
18. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
[TBL] [Abstract][Full Text] [Related]
19. Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain.
Hamidi GA; Ramezani MH; Arani MN; Talaei SA; Mesdaghinia A; Banafshe HR
Eur J Pharmacol; 2012 Jan; 674(2-3):260-4. PubMed ID: 22134003
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin alleviates neuropathic pain by inhibiting the MAPKs and NF-κB pathways.
Zhao L; Tao X; Song T
Eur J Pharmacol; 2021 Dec; 912():174575. PubMed ID: 34673033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
